美国食品药品监督管理局（FDA）批准了针对主导XFG变异株的更新版新冠疫苗 1。FDA允许Moderna、Novavax-Sanofi和辉瑞-BioNTech开始向全国药房和诊所发货 1。这些疫苗适用于65岁及以上人群，以及有基础疾病的年轻人群 1。各厂商年龄批准范围不同：Moderna疫苗批准用于6个月以上儿童，辉瑞-BioNTech疫苗批准用于5岁及以上人群，Novavax-Sanofi疫苗批准用于12岁及以上人群 1。
由于CDC疫苗顾问委员会自3月裁决以来处于停滞状态，保险公司是否覆盖这些疫苗尚不明确 1。卫生部长Robert F Kennedy Jr任命的疫苗顾问被阻止 1。
The U.S. Food and Drug Administration (FDA) has approved updated Covid-19 vaccines targeting the dominant XFG variant, allowing Moderna, Novavax-Sanofi, and Pfizer-BioNTech to begin shipping doses to pharmacies and clinics nationwide 1. These vaccines are intended for individuals aged 65 and older, as well as younger people with underlying health conditions 1. The approved age ranges vary by manufacturer: Moderna's vaccine is authorized for children aged 6 months and older, the Pfizer-BioNTech vaccine is approved for those aged 5 and up, and the Novavax-Sanofi vaccine is authorized for individuals aged 12 and older 1.
It remains unclear whether insurance companies will cover these updated vaccines, as the CDC's vaccine advisory committee has been stalled since its ruling in March 1. This paralysis follows the blocking of vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. 1.
评论
还没有评论，欢迎留下第一条。